Selective CDK7 Inhibitor
Highly selective CDK7 inhibitors are under optimization for cancer.
Poster
1. Highly selective, orally available CDK7 inhibitor for cancer therapy (2017 AACR-NCI-EORTC poster)
Highly selective CDK7 inhibitors are under optimization for cancer.
1. Highly selective, orally available CDK7 inhibitor for cancer therapy (2017 AACR-NCI-EORTC poster)